Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance–associated protein 2
暂无分享,去创建一个
[1] J. Dingemanse,et al. Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist , 2004, Clinical pharmacokinetics.
[2] Y. Bacq,et al. Intrahepatic cholestasis of pregnancy: A French prospective study , 1997, Hepatology.
[3] Richard J. Thompson,et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.
[4] P. Meier,et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. , 2000, Gastroenterology.
[5] J. Schellens,et al. Evidence for Two Interacting Ligand Binding Sites in Human Multidrug Resistance Protein 2 (ATP Binding Cassette C2)* , 2003, Journal of Biological Chemistry.
[6] R. Poupon,et al. Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan. , 2002, Journal of hepatology.
[7] Jürg Reichen,et al. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions , 2001, Clinical pharmacology and therapeutics.
[8] Y. Sugiyama,et al. Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[9] R. Evers,et al. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. , 2000, Molecular pharmacology.
[10] Y. Sugiyama,et al. Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. , 2003, Drug metabolism and pharmacokinetics.
[11] Richard J. Thompson,et al. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. , 2002, Gastroenterology.
[12] M. Clozel,et al. Inhibition of Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake Is the Major Determinant in the Pharmacokinetic Interaction between Bosentan and Cyclosporin A in the Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.
[13] X. Chu,et al. Transport of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate by the Multidrug Resistance Proteins MRP1, MRP2, and MRP3 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[14] P. Opolon,et al. Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man , 1992, Digestive Diseases and Sciences.
[15] T. Horie,et al. Mrp2/Abcc2 transport activity is stimulated by protein kinase Calpha in a baculo virus co-expression system. , 2005, Life sciences.